Sionna Therapeutics, Inc. (SION)
3.34
-0.09
(-2.62%)
USD |
NASDAQ |
Nov 13, 16:00
3.34
0.00 (0.00%)
After-Hours: 19:59
Sionna Therapeutics Market Cap : 151.02M for Nov. 13, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 12, 2026 | 155.09M |
| November 11, 2026 | 167.29M |
| November 10, 2026 | 167.29M |
| November 09, 2026 | 161.42M |
| November 06, 2026 | 148.30M |
| November 05, 2026 | 148.30M |
| November 04, 2026 | 168.46M |
| November 03, 2026 | 164.85M |
| November 02, 2026 | 168.46M |
| October 30, 2026 | 174.79M |
| October 29, 2026 | 180.66M |
| October 28, 2026 | 182.46M |
| October 27, 2026 | 174.79M |
| October 26, 2026 | 166.66M |
| October 23, 2026 | 162.59M |
| October 22, 2026 | 171.62M |
| October 21, 2026 | 174.79M |
| October 20, 2026 | 187.43M |
| October 19, 2026 | 181.11M |
| October 16, 2026 | 175.69M |
| October 15, 2026 | 184.27M |
| October 14, 2026 | 184.72M |
| October 13, 2026 | 197.82M |
| October 12, 2026 | 211.82M |
| October 09, 2026 | 221.30M |
| Date | Value |
|---|---|
| October 08, 2026 | 221.30M |
| October 07, 2026 | 217.69M |
| October 06, 2026 | 214.53M |
| October 05, 2026 | 219.05M |
| October 02, 2026 | 221.76M |
| October 01, 2026 | 230.34M |
| September 30, 2026 | 237.56M |
| September 29, 2026 | 232.60M |
| September 28, 2026 | 231.24M |
| September 25, 2026 | 236.21M |
| September 24, 2026 | 236.21M |
| September 23, 2026 | 248.85M |
| September 22, 2026 | 271.89M |
| September 21, 2026 | 270.99M |
| September 18, 2026 | 269.18M |
| September 17, 2026 | 324.28M |
| September 16, 2026 | 317.96M |
| September 15, 2026 | 310.73M |
| September 14, 2026 | 373.06M |
| September 11, 2026 | 354.54M |
| September 10, 2026 | 344.15M |
| September 09, 2026 | 337.83M |
| September 08, 2026 | 329.70M |
| September 04, 2026 | 324.28M |
| September 03, 2026 | 304.86M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Vertex Pharmaceuticals, Inc. | 136.55B |
| Capricor Therapeutics, Inc. | 553.48M |
| ARS Pharmaceuticals, Inc. | 391.47M |
| ACADIA Pharmaceuticals, Inc. | 3.238B |
| Immunic, Inc. | 102.88M |
Market Cap Related Metrics
| PEG Ratio | -0.0264 |
| Price to Book Value | 0.6279 |
| Price | 3.34 |
| Earnings Yield | -72.76% |
| PEGY Ratio | -0.0264 |